Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20971 AL 20985

Glucose transporters in brain in health and disease

Koepsell H.

Pflugers Arch. 2020 Sep;472(9):1299-1343. doi: 10.1007/s00424-020-02441-x. Epub 2020 Aug 13.

Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future

Mok VCT, Pendlebury S, Wong A, Alladi S, Au L, Bath PM, Biessels GJ, Chen C, Cordonnier C, Dichgans M, Dominguez J, Gorelick PB, Kim S, Kwok T, Greenberg SM, Jia J, Kalaria R, Kivipelto M, Naegandran K, Lam LCW, Lam BYK, Lee ATC, Markus HS, O'Brien J, Pai MC, Pantoni L, Sachdev P, Skoog I, Smith EE, Srikanth V, Suh GH, Wardlaw J, Ko H, Black SE, Scheltens P.

Alzheimers Dement. 2020 Nov;16(11):1571-1581. doi: 10.1002/alz.12143. Epub 2020 Aug 12.

Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field

Smedinga M, Darweesh SKL, Bloem BR, Post B, Richard E.

J Neurol. 2021 Feb;268(2):724-733. doi: 10.1007/s00415-020-10162-5. Epub 2020 Aug 18.

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review

Cooray R, Gupta V, Suphioglu C.

Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19.

Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia

Lesman-Segev OH, Edwards L, Rabinovici GD.

Semin Neurol. 2020 Aug;40(4):394-410. doi: 10.1055/s-0040-1715134. Epub 2020 Aug 20.

Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies

Henríquez G, Gomez A, Guerrero E, Narayan M.

ACS Chem Neurosci. 2020 Oct 7;11(19):2915-2934. doi: 10.1021/acschemneuro.0c00381. Epub 2020 Sep 11.

Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones

Cardoso S, Moreira PI.

Int Rev Neurobiol. 2020;155:37-64. doi: 10.1016/bs.irn.2020.02.010. Epub 2020 Aug 11.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.

Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.

Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351

Oh M, Oh SJ, Lee SJ, Oh JS, Roh JH, Chung SJ, Lee JH, Lee CS, Kim JS.

Clin Nucl Med. 2020 Nov;45(11):841-847. doi: 10.1097/RLU.0000000000003261.

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage

Farr AC, Xiong MP.

Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9.

Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases

Eleftheriadou D, Kesidou D, Moura F, Felli E, Song W.

Small. 2020 Oct;16(43):e1907308. doi: 10.1002/smll.201907308. Epub 2020 Sep 17.

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review

Manzoor S, Hoda N.

Eur J Med Chem. 2020 Nov 15;206:112787. doi: 10.1016/j.ejmech.2020.112787. Epub 2020 Sep 1.

Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution

Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R.

J Alzheimers Dis. 2020;78(2):479-503. doi: 10.3233/JAD-200891.

One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease

Catania M, Di Fede G.

Prog Mol Biol Transl Sci. 2020;175:213-237. doi: 10.1016/bs.pmbts.2020.07.003. Epub 2020 Aug 28.

Introduction of a Management Toolkit for Lewy Body Dementia: A Pilot Cluster-Randomized Trial

O'Brien JT, McKeith IG, Thomas AJ, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane JPM, Dunn S, Bentley A, Barker S, Mason J, Burn D, Taylor JP.

Mov Disord. 2021 Jan;36(1):143-151. doi: 10.1002/mds.28282. Epub 2020 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias